EXCISE TAX

Internal Revenue Bulletin 2013-34 · 2026-10-03 edition · updated 2026-10-04 · United States

Notice 2013–51, page 153. This notice provides guidance on the branded prescription drug fee for the 2014 fee year related to (1) the submission of Form 8947, Report of Branded Prescription Drug Information, (2) the time and manner for notifying covered entities of their preliminary fee calculation, (3) the time and manner for submitting error reports for the dispute resolution process, and (4) the

Finding Lists begin on page ii.

Get a plain-English answer with a citation back to this text.

Ask AI about this code

Export this section

▸Contents — Internal Revenue Bulletin 2013-34

Internal Revenue Bulletin 2013-34

GoCodebook provides public access, search, citation, multilingual explanation, and practical interpretation of legally adopted building regulations. It is not a substitute for the official ICC or California code publications.